# cardiovascular disease

An upstream push in prevention gained urgency with a projection that nearly one-third of women aged 22–44 could face cardiovascular disease by mid-century, compounded by early-life nutrition risks. Precision approaches in neurosurgery and anti-biofilm strategies signal more targeted interventions, while behavioral and electoral research shows how environments and inflation pressures shape outcomes. Coverage pullbacks for GLP-1 therapies underscore the tension between long-term health benefits and near-term costs.

New analyses indicate that evening chronotypes and age-specific trends are pushing cardiovascular prevention earlier. Trials suggest targeted nutrients improve sleep, while language and social signals help detect and buffer cognitive decline, pointing to scalable, evidence-based interventions.

New analyses link everyday exposures in light, alcohol, and aerosols to measurable health risks, while space microbiology and historical genomics reveal resilience and contamination challenges. Policy design also emerges as a decisive lever, with Norway achieving 94% electric-car sales despite demographic skepticism.